ALT vs ASML · rev $20.0K vs P/E 57, $665.37B cap
Altimmune Inc (ALT) versus ASML Holding NV ADR (ASML) — a side-by-side from cached financials, not a winner call.
Altimmune Inc (ALT) is a biotechnology company listed on US.
ASML Holding NV ADR (ASML) is a semiconductor equipment & materials company listed on US.
Latest reported ALT revenue for 2024-12-31 was $20.0K. Net income was -$95.1M. Revenue was down 95.3% from 2023-12-31 to 2024-12-31. ALT currently screens at market cap $527.0M.
ASML does not have a complete income-statement cache yet.
ALT currently screens at market cap $527.0M. ASML currently screens at market cap $665.37B and trailing P/E 57.5.
Not investment advice. Open the ALT and ASML stock pages for the full models.
Not investment advice.